Specificity of striatal dopamine D1 system in humans: implications for clinical use of D1 receptor-agonists in Parkinson's disease

Saved in:
Bibliographic Details
Published inFrontiers in Human Neuroscience Vol. 17; p. 1178616
Main Author Goto, Satoshi
Format Journal Article
LanguageEnglish
Published Lausanne Frontiers Media SA 26.04.2023
Frontiers Research Foundation
Frontiers Media S.A
Subjects
basal gangalia
Circuits
Dopamine
dopamine D1 agonist
Dopamine D1 receptors
drug therapy
Human Neuroscience
Movement disorders
Neostriatum
Neurodegenerative diseases
Neurosciences. Biological psychiatry. Neuropsychiatry
Parkinson's disease
RC321-571
striatum
Online AccessGet full text
ISSN1662-5161
1662-5161
DOI10.3389/fnhum.2023.1178616

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Edited by: Cornelius Bachmann, Independent Researcher, Osnabrück, Germany
Reviewed by: Luca Marsili, University of Cincinnati, United States
ISSN:1662-5161
1662-5161
DOI:10.3389/fnhum.2023.1178616